Th1 inflammatory response with altered expression of profibrotic and vasoactive mediators in AT1A and AT1B double-knockout mice

American Journal of Physiology - Renal Physiology

Volumn 289, Issue 4 58-4, 2005, Pages

  Ouyang, Xiaosen ^a   Le, Thu H ^b   Roncal, Carlos ^a   Gersch, Christine ^a   Herrera Acosta, Jaime ^c   Rodriguez Iturbe, Bernardo ^d   Coffman, Thomas M ^b   Johnson, Richard J ^a   Mu, Wei ^a  

^a UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

^b DUKE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c Department of Nephrology ^*  (Mexico)

^d HOSPITAL UNIVERSITARIO DE MARACAIBO   (Venezuela)

Author keywords

Cyclooxygenase 2; Endothelin; NADPH oxidase

Indexed keywords

ALPHA INTERFERON; ANGIOTENSIN 1 RECEPTOR; ANGIOTENSIN 1A RECEPTOR; ANGIOTENSIN 1B RECEPTOR; ANGIOTENSIN 2 RECEPTOR; CD11B ANTIGEN; CHEMOKINE; COLLAGEN TYPE 1; COLLAGEN TYPE 3; CYCLOOXYGENASE 2 INHIBITOR; ENDOTHELIN A RECEPTOR; INTERLEUKIN 2; MESSENGER RNA; MONOCYTE CHEMOTACTIC PROTEIN 1; PROTEIN P40; RANTES; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE; UNCLASSIFIED DRUG; VASOACTIVE AGENT;

ANIMAL TISSUE; ARTICLE; EXTRACELLULAR MATRIX; FIBROSIS; IMMUNOHISTOCHEMISTRY; INFLAMMATION; KIDNEY BLOOD FLOW; MACROPHAGE ACTIVATION; MEDIATOR RELEASE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; T LYMPHOCYTE ACTIVATION; VASCULAR DISEASE; WILD TYPE;

EID: 24944479890     PISSN: 1931857X     EISSN: 15221466     Source Type: Journal    
DOI: 10.1152/ajprenal.00141.2005     Document Type: Article

References (34)

1. Cheng HF, Wang JL, Zhang MZ, Miyazaki Y, Ichikawa I, McKanna JA, and Harris RC. Angiotensin II attenuates renal cortical cyclooxygenase-2 expression. J Clin Invest 103: 953-961, 1999.
2. 1) receptor functions through gene targeting. Acta Physiol Scand 181: 561-570, 2004.
3. Friberg P, Sundelin B, Bohman SO, Bobik A, Nilsson H, Wickman A, Gustafsson H, Petersen J, and Adams MA. Renin-angiotensin system in neonatal rats: induction of a renal abnormality in response to ACE inhibition or angiotensin II antagonism. Kidney Int 45: 485-492, 1994.
4. Furusu A, Miyazaki M, Abe K, Tsukasaki S, Shioshita K, Sasaki O, Miyazaki K, Ozono Y, Koji T, Harada T, Sakai H, and Kohno S. Expression of endothelial and inducible nitric oxide synthase in human glomerulonephritis. Kidney Int 53: 1760-1768, 1998.
5. Guron G, Adams MA, Sundelin B, and Friberg P. Neonatal angiotensin-converting enzyme inhibition in the rat induces persistent abnormalities in renal function and histology. Hypertension 29: 91-97, 1997.
6. Henry RJ, Sobel C, and Kim J. A modified carbonate-phosphotungstate method for the determination of uric acid and comparison with the spectrophotometric uricase method. Am J Clin Pathol 28: 152-160, 1957.
7. Ichihara A, Imig JD, Inscho EW, and Navar LG. Cyclooxygenase-2 participates in tubular flow-dependent afferent arteriolar tone: interaction with neuronal NOS. Am J Physiol Renal Physiol 275: F605-F612, 1998.
8. Jiang F, Drummond GR, and Dusting GJ. Suppression of oxidative stress in the endothelium and vascular wall. Endothelium 11: 79-88, 2004.
9. Johnson RJ, Rodriguez-Iturbe B, Schreiner GF, and Herrera-Acosta J. Hypertension: a microvascular and tubulointerstitial disease. J Hypertens 20, Suppl 3: S1-S7, 2002.
10. Kammerl MC, Richthammer W, Kurtz A, and Kramer BK. Angiotensin II feedback is a regulator of renocortical renin, COX-2, and nNOS expression. Am J Physiol Regul Integr Comp Physiol 282: R1613-R1617, 2002.
11. Kim HS, Krege JH, Kluckman KD, Hagaman JR, Hodgin JB, Best CF, Jennette JC, Coffman TM, Maeda N, and Smithies O. Genetic control of blood pressure and the angiotensinogen locus. Proc Natl Acad Sci USA 92: 2735-2739, 1995.
12. Krege JH, John SW, Langenbach LL, Hodgin JB, Hagaman JR, Bachman ES, Jennette JC, O'Brien DA, and Smithies O. Male female differences in fertility and blood pressure in ACE deficient mice. Nature 375: 146-148, 1995.
13. Le Meur Y, Jose MD, Mu W, Atkins RC, and Chadban SJ. Macrophage colony-stimulating factor expression and macrophage accumulation in renal allograft rejection. Transplantation 73: 1318-1324, 2002.
14. Manning RD Jr, Meng S, and Tian N. Renal and vascular oxidative stress and salt sensitivity of arterial pressure. Acta Physiol Scand 179: 243-250, 2003.
15. Matsusaka T and Ichikawa I. Biological functions of angiotensin and its receptors. Annu Rev Physiol 59: 395-412, 1997.
16. Michel JB, Guettier C, Philippe M, Galen FX, Corvol P, and Menard J. Active immunization against renin in normotensive marmoset. Proc Natl Acad Sci USA 84: 4346-4350, 1987.
17. Michel JB, Sayah S, Guettier C, Nussberger J, Philippe M, Gonzalez MF, Carelli C, Galen FX, Menard J, and Corvol P. Physiological and immunopathological consequences of active immunization of spontaneously hypertensive and normotensive rats against murine rennin. Circulation 81: 1899-1910, 1990.
18. 1-type angiotensin receptor in oxidative stress and atherogenesis. I. Oxidative stress and atherogenesis. Circulation 105: 393-396, 2002.
19. 1B receptors for angiotensin II. Proc Natl Acad Sci USA 95: 15496-15501, 1998.
20. Racasan S, Hahnel B, van der Giezen DM, Blezer EL, Goldschmeding R, Braam B, Kriz W, Koomans HA, and Joles JA. Temporary losartan or captopril in young SHR induces malignant hypertension despite initial normotension. Kidney Int 65: 575-581, 2004.
21. Rajagopalan S, Kurz S, Munzel T, Tarpey M, Freeman BA, Griendling KK, and Harrison DG. Angiotensin II-mediated hypertension in the rat increases vascular superoxide production via membrane NADH/NADPH oxidase activation. Contribution to alterations of vasomotor tone. J Clin Invest 97: 1916-1923, 1996.
22. Rodriguez-Iturbe B, Vaziri ND, Herrera-Acosta J, and Johnson RJ. Oxidative stress, renal infiltration of immune cells, and salt-sensitive hypertension: all for one and one for all. Am J Physiol Renal Physiol 286: F606-F616, 2004.
23. Romero JC and Reckelhoff JF. Role of angiotensin and oxidative stress in essential hypertension. Hypertension 34: 943-949, 1999.
24. Ruggenenti P. Angiotensin-converting enzyme inhibition and angiotensin II antagonism in nondiabetic chronic nephropathies. Semin Nephrol 24: 158-167, 2004.
25. Song WZ, Chen AF, and Wang DH. Increased salt sensitivity induced by sensory denervation: role of superoxide. Acta Pharmacol Sin 25: 1626-1632, 2004.
26. Tojo A. Onozato ML, Fukuda S, Asaba K, Kimura K, and Fujita T. Nitric oxide generated by nNOS in the macula densa regulates the afferent arteriolar diameter in rat kidney. Med Electron Microsc 37: 236-241, 2004.
27. Touyz RM and Berry C. Recent advances in angiotensin II signaling. Braz J Med Biol Res 35: 1001-1015, 2002.
28. Tsuchida S, Matsusaka T, Chen X, Okubo S, Niimura F, Nishimura H, Fogo A, Utsunomiya H, Inagami T, and Ichikawa I. Murine double nullizygotes of the angiotensin type 1A and 1B receptor genes duplicate severe abnormal phenotypes of angiotensinogen nullizygotes. J Clin Invest 101: 755-760, 1998.
29. Tufro-McReddie A, Romano LM, Harris JM, Ferder L, and Gomez RA. Angiotensin II regulates nephrogenesis and renal vascular development. Am J Physiol Renal Fluid Electrolyte Physiol 269: F110-F115, 1995.
30. Unger T. Blood pressure lowering and renin-angiotensin system blockade. J Hypertens 21, Suppl 6: S3-S7, 2003.
31. 1 receptor antagonist combats oxidative stress and restores nitric oxide signaling in the SHR. Kidney Int 59: 1257-1263, 2001.
32. Wilcox CS. Reactive oxygen species: roles in blood pressure, and kidney function. Curr Hypertens Rep 4: 160-166, 2002.
33. Yanai K, Saito T, Kakinuma Y, Kon Y, Hirota K, Taniguchi-Yanai K, Nishijo N, Shigematsu Y, Horiguchi H, Kasuya Y, Sugiyama F, Yagami K, Murakami K, and Fukamizu A. Renin dependent cardiovascular functions and renin-independent blood-brain barrier functions revealed by renin-deficient mice. J Biol Chem 275: 5-8, 2000.
34. Zhang JJ, Bledsoe G, Kato K, Chao L, and Chao J. Tissue kallikrein attenuates salt-induced renal fibrosis by inhibition of oxidative stress. Kidney Int 66: 722-732, 2004.